Cargando…

Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility

BACKGROUND: Epidemiological studies recognize cannabis intake as a risk factor for schizophrenia, yet the majority of adolescents who use marijuana do not develop psychosis. Similarly, the abuse of synthetic cannabinoids poses a risk for psychosis. For these reasons, it is imperative to understand t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguilar, David D, Giuffrida, Andrea, Lodge, Daniel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887672/ https://www.ncbi.nlm.nih.gov/pubmed/29329382 http://dx.doi.org/10.1093/ijnp/pyy003

Ejemplares similares

Increased Presynaptic Dopamine Synthesis Capacity Is Associated With Aberrant Dopamine Neuron Activity in the Methylazoxymethanol Acetate Rodent Model Used to Study Schizophrenia-Related Pathologies
por: Perez, Stephanie M, et al.
Publicado: (2022)

Orexin Modulation of VTA Dopamine Neuron Activity: Relevance to Schizophrenia
por: Perez, Stephanie M, et al.
Publicado: (2021)

Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia
por: Aguilar, David D, et al.
Publicado: (2014)

Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia
por: Perez, Stephanie M., et al.
Publicado: (2013)

O9.5. ABERRANT DOPAMINE SYSTEM FUNCTION REVERSED BY THE OREXIN RECEPTOR ANTAGONIST TCS1102 IN A RODENT MODEL OF SCHIZOPHRENIA
por: Perez, Stephanie, et al.
Publicado: (2018)

A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia
por: Shah, A, et al.
Publicado: (2013)

Adult stress exposure blunts dopamine system hyperresponsivity in a neurodevelopmental rodent model of schizophrenia
por: Rincón-Cortés, Millie, et al.
Publicado: (2022)

Receptor Heteromerization Expands the Repertoire of Cannabinoid Signaling in Rodent Neurons
por: Rozenfeld, Raphael, et al.
Publicado: (2012)

Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia
por: Satodiya, Ritvij, et al.
Publicado: (2020)

Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring
por: Pinky, Priyanka D., et al.
Publicado: (2021)

Gestational Buprenorphine Exposure Disrupts Dopamine Neuron Activity and Related Behaviors in Adulthood
por: Elam, Hannah B., et al.
Publicado: (2022)

Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia
por: Gleason, K A, et al.
Publicado: (2012)

Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients
por: Katthagen, Teresa, et al.
Publicado: (2020)

The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
por: Terzian, Ana Luisa, et al.
Publicado: (2011)

The Roles of Dopamine D1 Receptor on the Social Hierarchy of Rodents and Nonhuman Primates
por: Yamaguchi, Yoshie, et al.
Publicado: (2016)

Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014)

Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis
por: Elam, Hannah B., et al.
Publicado: (2021)

Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice
por: Aguilar, María A., et al.
Publicado: (2017)

Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease()
por: Schlaudraff, Falk, et al.
Publicado: (2014)

Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction
por: Nakao, Kazuhito, et al.
Publicado: (2019)

PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice
por: Xi, Zheng-Xiong, et al.
Publicado: (2023)

New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways
por: Perez, Stephanie M, et al.
Publicado: (2014)

Selective Deletion of the Leptin Receptor in Dopamine Neurons Produces Anxiogenic-like Behavior and Increases Dopaminergic Activity in Amygdala
por: Liu, Jing, et al.
Publicado: (2011)

Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophrenia
por: Perez, Stephanie M., et al.
Publicado: (2019)

Nicotine Administration Normalizes Behavioral and Neurophysiological Perturbations in the MAM Rodent Model of Schizophrenia
por: Weeks, Jillian J, et al.
Publicado: (2021)

Synaptic Neurotransmission Depression in Ventral Tegmental Dopamine Neurons and Cannabinoid-Associated Addictive Learning
por: Liu, Zhiqiang, et al.
Publicado: (2010)

Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia
por: Donegan, Jennifer J., et al.
Publicado: (2020)

Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents
por: Hur, Kwang-Hyun, et al.
Publicado: (2022)

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy
por: Harman, Thomas, et al.
Publicado: (2023)

Effectiveness of the synthetic cannabinoids seminar
por: Seyit, Murat, et al.
Publicado: (2016)

Synthetic cannabinoids and renal injury
por: Alp, Alper
Publicado: (2015)

Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia
por: Kubota, Manabu, et al.
Publicado: (2017)

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
por: Liu, Qing-Rong, et al.
Publicado: (2020)

Peri-Pubertal Emergence of UNC-5 Homologue Expression by Dopamine Neurons in Rodents
por: Manitt, Colleen, et al.
Publicado: (2010)

Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents
por: He, Yachao, et al.
Publicado: (2023)

Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia
por: Falkenberg, Liv E., et al.
Publicado: (2014)

Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia
por: Sauerzopf, U., et al.
Publicado: (2021)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia
por: Purves-Tyson, Tertia D., et al.
Publicado: (2021)

Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function
por: Renard, Justine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7a5nk50aihqff43kgkek8dmggq